These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 13641436

  • 1. The sensitivity of staphylococci and other wound bacteria to erythromycin, oleandomycin, and spiramycin.
    LOWBURY EJ, HURST L.
    J Clin Pathol; 1959 Mar; 12(2):163-9. PubMed ID: 13641436
    [No Abstract] [Full Text] [Related]

  • 2. Development of resistance and cross-resistance in vitro to erythromycin, carbomycin, spiramycin, oleandomycin and streptogramin.
    FINLAND M, JONES WF, NICHOLS RL.
    Proc Soc Exp Biol Med; 1956 Nov; 93(2):388-93. PubMed ID: 13379520
    [No Abstract] [Full Text] [Related]

  • 3. A comparison of erythromycin with oleandomycin in combination with other antibiotics against hospital staphylococci.
    ELLIOTT HJ, HALL WH.
    J Lab Clin Med; 1959 Mar; 53(3):364-75. PubMed ID: 13631321
    [No Abstract] [Full Text] [Related]

  • 4. [Comparative study of the antistaphylococcal bacteriostatic activity of 4 antibiotics: erythromycin, spiramycin, oleandomycin and novobiocin].
    BURDIN JC, SCHMITT J, de LAVERGNE.
    Rev Med Nancy; 1959 Oct; 84():930-3. PubMed ID: 13806021
    [No Abstract] [Full Text] [Related]

  • 5. The effects of vancomycin, oleandomycin, and novobiocin and staphylococci in vitro.
    RANTZ LA, RANDALL E, THUM L, BARKER LF.
    Antibiot Chemother (Northfield); 1957 Aug; 7(8):399-409. PubMed ID: 24544513
    [No Abstract] [Full Text] [Related]

  • 6. Transduction of resistance to some macrolide antibiotics in Staphylococcus aureus.
    PATTEE PA, BALDWIN JN.
    J Bacteriol; 1962 Nov; 84(5):1049-55. PubMed ID: 13941896
    [Abstract] [Full Text] [Related]

  • 7. In vitro sensitivity of erythromycin-resistant strains of staphylococci and enterococci to vancomycin and novobiocin.
    SCHNEIERSON SS, AMSTERDAM D.
    Antibiot Chemother (Northfield); 1957 May; 7(5):251-4. PubMed ID: 24544426
    [No Abstract] [Full Text] [Related]

  • 8. [Development and modifications of the resistance of pathogenic staphylococci to six common antibiotics from 1950 to 1956; comparative action in vitro of erythromycin, magnamycin, spiramycin, novobiocin (albamycin) and oleandomycin].
    LUTZ A, GROOTTEN O, HOFFERER MJ.
    Ann Inst Pasteur (Paris); 1957 Jun; 92(6):778-89. PubMed ID: 13444794
    [No Abstract] [Full Text] [Related]

  • 9. [Resistance characteristics in hospital material, with special reference to staphylococcic and enterococcic sensitivity to erythromycin].
    KYLIN O.
    Sven Lakartidn; 1956 Sep 07; 53(36):2259-67. PubMed ID: 13360709
    [No Abstract] [Full Text] [Related]

  • 10. Antibiotic mixtures; in vitro effect of a tetracycline-oleandomycin mixture (PA 775) on staphylococci.
    Levitt RO, Hubble RH.
    N Engl J Med; 1957 Jul 25; 257(4):180-1. PubMed ID: 13452068
    [No Abstract] [Full Text] [Related]

  • 11. [In vitro antagonism between erythromycin and spiramycin].
    CHABBERT Y.
    Ann Inst Pasteur (Paris); 1956 Jun 25; 90(6):787-90. PubMed ID: 13340322
    [No Abstract] [Full Text] [Related]

  • 12. Staphylococcal resistance to ristocetin, oleandomycin, and novobiocin.
    HSIE JY, NUSSER W, EPSTEIN S, VAN MAREN H, OZOG S.
    Antibiot Chemother (Northfield); 1958 Dec 25; 8(12):607-14. PubMed ID: 24545054
    [No Abstract] [Full Text] [Related]

  • 13. [In vitro activity of spiramycin in combination with tetracycline, erythromycin, penicillin, streptomycin, on Staphylococcus aureus multiplication, studied by microbiophotometer].
    Mathieu N, Faguet M.
    Ann Inst Pasteur (Paris); 1958 Jan 25; 94(1):69-77. PubMed ID: 13509310
    [No Abstract] [Full Text] [Related]

  • 14. DRUG RESISTANCE OF STAPHYLOCOCCI. II. JOINT ELIMINATION AND JOINT TRANSDUCTION OF THE DETERMINANTS OF PENICILLINASE PRODUCTION AND RESISTANCE TO MACROLIDE ANTIBIOTICS.
    MITSUHASHI S, HASHIMOTO H, KONO M, MORIMURA M.
    J Bacteriol; 1965 Apr 25; 89(4):988-92. PubMed ID: 14276126
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Laboratory studies of oleandomycin (matromycin).
    GERACI JE, NEEDHAM GM.
    Antibiotic Med Clin Ther (New York); 1956 Oct 25; 3(5):334-5. PubMed ID: 13363377
    [No Abstract] [Full Text] [Related]

  • 17. Influence of a combination of sodium sulfisoxazole and oleandomycin phosphate on the development of drug resistance of Micrococcus pyogenes var. aureus in vitro.
    DELORENZO WF.
    Antibiot Chemother (Northfield); 1958 Feb 25; 8(2):84-5. PubMed ID: 24544672
    [No Abstract] [Full Text] [Related]

  • 18. In-vitro activity of sigmamycin: a combination of tetracycline and oleandomycin.
    FAIRBROTHER RW, SOUTHALL JE.
    Lancet; 1957 Nov 16; 273(7003):974-6. PubMed ID: 13482262
    [No Abstract] [Full Text] [Related]

  • 19. Separation and determination of the macrolide antibiotics (erythromycin, spiramycin and oleandomycin) by capillary electrophoresis coupled with fast reductive voltammetric detection.
    Zhou J, Chen Y, Cassidy R.
    Electrophoresis; 2000 Apr 16; 21(7):1349-53. PubMed ID: 10826680
    [Abstract] [Full Text] [Related]

  • 20. Antibiotic combinations; antistreptococcal and antistaphylococcal activity of plasma of normal subjects after oral doses of penicillin, oleandomycin and combinations of these antibiotics.
    FINLAND M, JONES WF.
    N Engl J Med; 1957 Jan 17; 256(3):115-9. PubMed ID: 13388042
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.